In a study on DNA vaccine in phase I clinical trial, CEA tumor antigen-encoding plasmid (pCEA/HBsAg) and Hepatitis B Surface Antigen (HBsAg) were used in 17 patients with m CRC. This evidence concerns the gene LINC01194 and colorectal carcinoma.